Physician

Tansel Turgut, M.D.

According to 2025 Medicare claims, Tansel Turgut, M.D. (NPI: 1104829886) practices interventional cardiology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is FRANCISCAN PHYSICIAN NETWORK (NPI: 1225327984; TIN: 611630276) and primary practice location at 46360-0021. Turgut is affiliated with the CHA ACO, LLC (ACO ID: A2207) and Franciscan ACO, Inc. (ACO ID: A2550), participating under the MSSP model.

Turgut's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 760 traditional Medicare patients, billed 1,583 HCPCS/CPT codes, and received $80,556 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,816 prescription claims across 347 beneficiaries totaling $230,777 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 38 records totaling $2,939. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $140,706 to $80,556. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $87,434 and ending at $230,777. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,745	5,237	$140,706
2016	2,371	4,824	$151,724
2017	2,538	4,892	$130,258
2018	2,409	4,817	$145,383
2019	2,422	4,829	$147,336
2020	2,092	3,993	$112,480
2021	1,733	3,339	$96,010
2022	341	855	$69,641
2023	318	871	$64,153
2024	760	1,583	$80,556

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	245	2,741	$87,434
2016	266	2,755	$117,124
2017	294	2,760	$176,171
2018	316	3,077	$217,836
2019	345	3,112	$212,806
2020	353	3,043	$194,127
2021	336	2,689	$187,266
2022	293	1,111	$101,856
2023	198	1,058	$113,156
2024	347	1,816	$230,777

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	111	121	$75
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	159	159	$68
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	93	137	$57
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	232	253	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	180	211	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	95	4,914	$94,039
Entresto	Sacubitril/Valsartan	21	1,540	$34,251
Brilinta	Ticagrelor	37	2,166	$32,008
Xarelto	Rivaroxaban	22	1,560	$28,615
Metoprolol Succinate	Metoprolol Succinate	281	25,017	$2,920

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$2,939	Penumbra, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tansel Turgut, M.D.?

Tedicare shows public-source Medicare data for Tansel Turgut, M.D. (NPI 1104829886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tansel Turgut, M.D. have ACO affiliation data?

Tansel Turgut, M.D. is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207) and Franciscan ACO, Inc. (MSSP, ACO ID A2550).

What billing organization is linked to Tansel Turgut, M.D.?

Tansel Turgut, M.D. is linked to FRANCISCAN PHYSICIAN NETWORK (billing NPI 1225327984) in the available physician profile data.

Does Tansel Turgut, M.D. have Open Payments data?

Tansel Turgut, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.